|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
17.05/25.07
|
Enterprise Value
182.12B
|
Balance Sheet |
Book Value Per Share
130.84
|
Cash Flow |
Cash Flow Yield
0.05
|
Income Statement |
Total Revenue
42.88B
|
Operating Revenue Per Share
115.02
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%). |